Why the study?
Does an elevated cytokine profile predict cardiovascular complications in patients with STEMI?
Does an elevated cytokine profile predict cardiovascular complications in patients with STEMI?
Answers are grounded in this paper and cite their sources.
Initially elevated levels of CRP, TNFα, IL-6, and IL-10 in the blood can identify STEMI patients at high risk of cardiovascular events within 1 year.
The aim of this study was to evaluate the prognostic role of the cytokine profile in patients with ST segment elevation myocardial infarction (STEMI). Materials and methods. In the present paper we studied cytokines IL-6, IL-1β, IL-10, TNFα and CRP in 81 patients with different course of STEMI. Results. In patients with complicated course of STEMI a significant increase in the concentration of IL-6, IL-10, FNOα, CRP was recorded on the 1st, 7th and 14th days compared with control group of healthy subjects and a group of patients with uncomplicated STEMI. Concentrations of TNFα>35.49 pg/ml, IL-6>33.37 pg/ml, IL-10>34 pg/ml, CRP>10.84 mg/l on day 1 may suggest cardiovascular complications in STEMI patients within 1 year after the onset of the disease. We have not found reliable prognostic levels of IL-1β, as the concentration of this cytokine remained within the accepted normal range.. Discussion. It is concluded that initially elevated levels of CRP l, TNFα, IL-6, IL-10 in the blood make it possible to identify groups of patients with myocardial infarction with ST-segment elevation at high risk of cardiovascular events throughout the year.
No takes yet. Share an insight, caveat, or question.
Аймагамбетова et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: